Chenyang Li
Hebei Medical University
9 Papers
Chenyang Li is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Medicine & Microvesicles. The author has co-authored 1 publications.
Chat about Author
Papers
Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway.
Yaxing Kang,Yirang Song,Yuxin Luo,Jia Song,Chenyang Li,Shuangshuang Yang,Jinbo Guo,Jun Yu,Xiaolan Zhang +8 more
TL;DR: Wang et al. as discussed by the authors investigated the effects of hUC-MSCs exosomes on NASH through Nrf2/NQO-1 pathway in vivo and in vitro.
64
CCN6 improves hepatic steatosis, inflammation, and fibrosis in non‐alcoholic steatohepatitis
Yiran Song,Chenyang Li,Yuxin Luo,Jinbo Guo,Yaxing Kang,Fengrong Yin,Li-hong Ye,Donglei sun,Jun Yu,Xiaolan Zhang +9 more
TL;DR: CCN6 protects against hepatic steatosis, inflammation response and fibrosis by inhibiting the activation of ASK1 along with its downstream MAPK signaling and may be a potential therapeutic target for the treatment of NASH.
8
HucMSC-Exo Promote Mucosal Healing in Experimental Colitis by Accelerating Intestinal Stem Cells and Epithelium Regeneration via Wnt Signaling Pathway
X. Liang,Chenyang Li,Jia Song,Airu Liu,Wenxin Wang,Yaxing Kang,Donglei sun,Jiaming Qian,Xiaolan Zhang +8 more
TL;DR: Wang et al. as discussed by the authors showed that exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs) were subjected to experimental colitis mice intraperitoneally to estimate the role in mucosal healing and the regeneration of intestinal stem cells and epithelium.
4
Long non‑coding RNA Mirt2 interacts with long non‑coding RNA IFNG‑AS1 to regulate ulcerative colitis
TL;DR: Mirt2 may interact with IFNG-AS1 during UC to participate in colonic epithelial cell apoptosis, which is a key initiator of ulcerative colitis.
Impact of Mesenchymal Stem Cells on the Gut Microbiota and Microbiota Associated Functions in Inflammatory Bowel Disease: A Systematic Review of Preclinical Evidence on Animal Models.
Airu Liu,Chenyang Li,Chen Wang,Xiaonan Liang,Xiaolan Zhang +4 more
TL;DR: Current data support the remodeling effect on gut microbiota with MSC administration, which provides a potential therapeutic mechanism for MSCs in the treatment of IBD.
2